Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 184

1.

Broad-Range Papillomavirus Transcriptome as a Biomarker of Papillomavirus-Associated Cervical High-Grade Cytology.

Pérot P, Biton A, Marchetta J, Pourcelot AG, Nazac A, Marret H, Hébert T, Chrétien D, Demazoin MC, Falguières M, Arowas L, Laude H, Heard I, Eloit M.

J Mol Diagn. 2019 Sep;21(5):768-781. doi: 10.1016/j.jmoldx.2019.04.010. Epub 2019 Aug 12.

PMID:
31416693
2.

The rabbit as an orthologous small animal model for APOBEC3A oncogenesis.

Laude HC, Caval V, Bouzidi MS, Li X, Jamet F, Henry M, Suspène R, Wain-Hobson S, Vartanian JP.

Oncotarget. 2018 Jun 12;9(45):27809-27822. doi: 10.18632/oncotarget.25593. eCollection 2018 Jun 12.

3.

A stretch of residues within the protease-resistant core is not necessary for prion structure and infectivity.

Munoz-Montesino C, Sizun C, Moudjou M, Herzog L, Reine F, Igel-Egalon A, Barbereau C, Chapuis J, Ciric D, Laude H, Béringue V, Rezaei H, Dron M.

Prion. 2017 Jan 2;11(1):25-30. doi: 10.1080/19336896.2016.1274851. Epub 2017 Feb 8.

4.

Divergent prion strain evolution driven by PrPC expression level in transgenic mice.

Le Dur A, Laï TL, Stinnakre MG, Laisné A, Chenais N, Rakotobe S, Passet B, Reine F, Soulier S, Herzog L, Tilly G, Rézaei H, Béringue V, Vilotte JL, Laude H.

Nat Commun. 2017 Jan 23;8:14170. doi: 10.1038/ncomms14170.

5.

Self-cytoplasmic DNA upregulates the mutator enzyme APOBEC3A leading to chromosomal DNA damage.

Suspène R, Mussil B, Laude H, Caval V, Berry N, Bouzidi MS, Thiers V, Wain-Hobson S, Vartanian JP.

Nucleic Acids Res. 2017 Apr 7;45(6):3231-3241. doi: 10.1093/nar/gkx001.

6.

Absence of Evidence for a Causal Link between Bovine Spongiform Encephalopathy Strain Variant L-BSE and Known Forms of Sporadic Creutzfeldt-Jakob Disease in Human PrP Transgenic Mice.

Jaumain E, Quadrio I, Herzog L, Reine F, Rezaei H, Andréoletti O, Laude H, Perret-Liaudet A, Haïk S, Béringue V.

J Virol. 2016 Nov 14;90(23):10867-10874. doi: 10.1128/JVI.01383-16. Print 2016 Dec 1.

7.

Glycoform-independent prion conversion by highly efficient, cell-based, protein misfolding cyclic amplification.

Moudjou M, Chapuis J, Mekrouti M, Reine F, Herzog L, Sibille P, Laude H, Vilette D, Andréoletti O, Rezaei H, Dron M, Béringue V.

Sci Rep. 2016 Jul 7;6:29116. doi: 10.1038/srep29116.

8.

Generating Bona Fide Mammalian Prions with Internal Deletions.

Munoz-Montesino C, Sizun C, Moudjou M, Herzog L, Reine F, Chapuis J, Ciric D, Igel-Egalon A, Laude H, Béringue V, Rezaei H, Dron M.

J Virol. 2016 Jul 11;90(15):6963-6975. doi: 10.1128/JVI.00555-16. Print 2016 Aug 1.

9.

Emergence of two prion subtypes in ovine PrP transgenic mice infected with human MM2-cortical Creutzfeldt-Jakob disease prions.

Chapuis J, Moudjou M, Reine F, Herzog L, Jaumain E, Chapuis C, Quadrio I, Boulliat J, Perret-Liaudet A, Dron M, Laude H, Rezaei H, Béringue V.

Acta Neuropathol Commun. 2016 Feb 5;4:10. doi: 10.1186/s40478-016-0284-9.

10.

Prion protein localizes at the ciliary base during neural and cardiovascular development, and its depletion affects α-tubulin post-translational modifications.

Halliez S, Martin-Lannerée S, Passet B, Hernandez-Rapp J, Castille J, Urien C, Chat S, Laude H, Vilotte JL, Mouillet-Richard S, Béringue V.

Sci Rep. 2015 Dec 18;5:17146. doi: 10.1038/srep17146.

11.

Mutated but Not Deleted Ovine PrP(C) N-Terminal Polybasic Region Strongly Interferes with Prion Propagation in Transgenic Mice.

Khalifé M, Reine F, Paquet-Fifield S, Castille J, Herzog L, Vilotte M, Moudjou M, Moazami-Goudarzi K, Makhzami S, Passet B, Andréoletti O, Vilette D, Laude H, Béringue V, Vilotte JL.

J Virol. 2015 Nov 25;90(3):1638-46. doi: 10.1128/JVI.02805-15. Print 2016 Feb 1.

12.

Prognostic value of antibodies to Merkel cell polyomavirus T antigens and VP1 protein in patients with Merkel cell carcinoma.

Samimi M, Molet L, Fleury M, Laude H, Carlotti A, Gardair C, Baudin M, Gouguet L, Maubec E, Avenel-Audran M, Esteve E, Wierzbicka-Hainaut E, Beneton N, Aubin F, Rozenberg F, Dupin N, Avril MF, Lorette G, Guyetant S, Coursaget P, Touzé A.

Br J Dermatol. 2016 Apr;174(4):813-22. doi: 10.1111/bjd.14313. Epub 2016 Feb 3.

PMID:
26600395
13.

Molecular basis of the attenuated phenotype of human APOBEC3B DNA mutator enzyme.

Caval V, Bouzidi MS, Suspène R, Laude H, Dumargne MC, Bashamboo A, Krey T, Vartanian JP, Wain-Hobson S.

Nucleic Acids Res. 2015 Oct 30;43(19):9340-9. doi: 10.1093/nar/gkv935. Epub 2015 Sep 17.

14.

Transgenic Rabbits Expressing Ovine PrP Are Susceptible to Scrapie.

Sarradin P, Viglietta C, Limouzin C, Andréoletti O, Daniel-Carlier N, Barc C, Leroux-Coyau M, Berthon P, Chapuis J, Rossignol C, Gatti JL, Belghazi M, Labas V, Vilotte JL, Béringue V, Lantier F, Laude H, Houdebine LM.

PLoS Pathog. 2015 Aug 6;11(8):e1005077. doi: 10.1371/journal.ppat.1005077. eCollection 2015 Aug.

15.

To develop with or without the prion protein.

Halliez S, Passet B, Martin-Lannerée S, Hernandez-Rapp J, Laude H, Mouillet-Richard S, Vilotte JL, Béringue V.

Front Cell Dev Biol. 2014 Oct 13;2:58. doi: 10.3389/fcell.2014.00058. eCollection 2014. Review.

16.

The prion protein family: a view from the placenta.

Makzhami S, Passet B, Halliez S, Castille J, Moazami-Goudarzi K, Duchesne A, Vilotte M, Laude H, Mouillet-Richard S, Béringue V, Vaiman D, Vilotte JL.

Front Cell Dev Biol. 2014 Aug 8;2:35. doi: 10.3389/fcell.2014.00035. eCollection 2014. Review.

17.

Accelerated, spleen-based titration of variant Creutzfeldt-Jakob disease infectivity in transgenic mice expressing human prion protein with sensitivity comparable to that of survival time bioassay.

Halliez S, Reine F, Herzog L, Jaumain E, Haïk S, Rezaei H, Vilotte JL, Laude H, Béringue V.

J Virol. 2014 Aug;88(15):8678-86. doi: 10.1128/JVI.01118-14. Epub 2014 May 21.

18.

Highly infectious prions generated by a single round of microplate-based protein misfolding cyclic amplification.

Moudjou M, Sibille P, Fichet G, Reine F, Chapuis J, Herzog L, Jaumain E, Laferrière F, Richard CA, Laude H, Andréoletti O, Rezaei H, Béringue V.

MBio. 2013 Dec 31;5(1):e00829-13. doi: 10.1128/mBio.00829-13.

19.

Quaternary structure of pathological prion protein as a determining factor of strain-specific prion replication dynamics.

Laferrière F, Tixador P, Moudjou M, Chapuis J, Sibille P, Herzog L, Reine F, Jaumain E, Laude H, Rezaei H, Béringue V.

PLoS Pathog. 2013;9(10):e1003702. doi: 10.1371/journal.ppat.1003702. Epub 2013 Oct 10.

20.

Decontamination of prions in a plasma product manufacturing environment.

Bellon A, Comoy E, Simoneau S, Mornac S, Dehen C, Perrin A, Arzel A, Arrabal S, Baron H, Laude H, You B, Deslys JP, Flan B.

Transfusion. 2014 Apr;54(4):1028-36. doi: 10.1111/trf.12381. Epub 2013 Aug 27.

PMID:
24032663
21.

Trichodysplasia spinulosa associated with lupus.

Moktefi A, Laude H, Brudy Gulphe L, Rozenberg F, Vacher Lavenu MC, Dupin N, Carlotti A.

Am J Dermatopathol. 2014 Mar;36(3):e70-4. doi: 10.1097/DAD.0b013e318293f620.

PMID:
23928454
22.

Plasminogen-based capture combined with amplification technology for the detection of PrP(TSE) in the pre-clinical phase of infection.

Segarra C, Bougard D, Moudjou M, Laude H, Béringue V, Coste J.

PLoS One. 2013 Jul 24;8(7):e69632. doi: 10.1371/journal.pone.0069632. Print 2013.

23.

Fulminant type 1 diabetes in the course of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome.

Dubois-Laforgue D, Moachon L, Laude H, Timsit J.

Diabetes Care. 2013 May;36(5):e68. doi: 10.2337/dc12-2107. No abstract available.

24.

The case | Post-tranplant allograft dysfunction.

Aubert O, Galmiche L, Rozenberg F, Duquesne A, Scemla A, Rabant M, Leruez M, Laude H, Legendre C, Sberro-Soussan R.

Kidney Int. 2013 Apr;83(4):765-7. doi: 10.1038/ki.2013.1. No abstract available.

25.

Glycoform-selective prion formation in sporadic and familial forms of prion disease.

Xiao X, Yuan J, Haïk S, Cali I, Zhan Y, Moudjou M, Li B, Laplanche JL, Laude H, Langeveld J, Gambetti P, Kitamoto T, Kong Q, Brandel JP, Cobb BA, Petersen RB, Zou WQ.

PLoS One. 2013;8(3):e58786. doi: 10.1371/journal.pone.0058786. Epub 2013 Mar 19.

26.

Targeted knock-down of cellular prion protein expression in myelinating Schwann cells does not alter mouse prion pathogenesis.

Halliez S, Chesnais N, Mallucci G, Vilotte M, Langevin C, Jaumain E, Laude H, Vilotte JL, Béringue V.

J Gen Virol. 2013 Jun;94(Pt 6):1435-40. doi: 10.1099/vir.0.049619-0. Epub 2013 Feb 6.

PMID:
23388201
27.

Vitamin D deficiency is associated with greater tumor size and poorer outcome in Merkel cell carcinoma patients.

Samimi M, Touzé A, Laude H, Le Bidre E, Arnold F, Carpentier A, Gardair C, Carlotti A, Maubec E, Dupin N, Aubin F, Avril MF, Rozenberg F, Avenel-Audran M, Guyetant S, Lorette G, Machet L, Coursaget P.

J Eur Acad Dermatol Venereol. 2014 Mar;28(3):298-308. doi: 10.1111/jdv.12101. Epub 2013 Feb 1.

PMID:
23368852
28.

Mammalian prions: tolerance to sequence changes-how far?

Salamat MK, Munoz-Montesino C, Moudjou M, Rezaei H, Laude H, Béringue V, Dron M.

Prion. 2013 Mar-Apr;7(2):131-5. doi: 10.4161/pri.23110. Epub 2012 Dec 11. Review.

29.

The prion protein family: looking outside the central nervous system.

Passet B, Halliez S, Béringue V, Laude H, Vilotte JL.

Prion. 2013 Mar-Apr;7(2):127-30. doi: 10.4161/pri.22851. Epub 2012 Nov 15. Review.

30.

Prion protein and Shadoo are involved in overlapping embryonic pathways and trophoblastic development.

Passet B, Young R, Makhzami S, Vilotte M, Jaffrezic F, Halliez S, Bouet S, Marthey S, Khalifé M, Kanellopoulos-Langevin C, Béringue V, Le Provost F, Laude H, Vilotte JL.

PLoS One. 2012;7(7):e41959. doi: 10.1371/journal.pone.0041959. Epub 2012 Jul 30.

31.

[Tissue-specific cross-species transmission of prions].

Béringue V, Vilotte JL, Laude H.

Med Sci (Paris). 2012 Jun-Jul;28(6-7):565-8. doi: 10.1051/medsci/2012286002. Epub 2012 Jul 16. French. No abstract available.

32.

Endogenous prion protein conversion is required for prion-induced neuritic alterations and neuronal death.

Cronier S, Carimalo J, Schaeffer B, Jaumain E, Béringue V, Miquel MC, Laude H, Peyrin JM.

FASEB J. 2012 Sep;26(9):3854-61. doi: 10.1096/fj.11-201772. Epub 2012 Jun 1.

PMID:
22661006
33.

Integrity of helix 2-helix 3 domain of the PrP protein is not mandatory for prion replication.

Salamat K, Moudjou M, Chapuis J, Herzog L, Jaumain E, Béringue V, Rezaei H, Pastore A, Laude H, Dron M.

J Biol Chem. 2012 Jun 1;287(23):18953-64. doi: 10.1074/jbc.M112.341677. Epub 2012 Apr 16.

34.

Arsenic trioxide prevents murine sclerodermatous graft-versus-host disease.

Kavian N, Marut W, Servettaz A, Laude H, Nicco C, Chéreau C, Weill B, Batteux F.

J Immunol. 2012 May 15;188(10):5142-9. doi: 10.4049/jimmunol.1103538. Epub 2012 Apr 9.

35.

Facilitated cross-species transmission of prions in extraneural tissue.

Béringue V, Herzog L, Jaumain E, Reine F, Sibille P, Le Dur A, Vilotte JL, Laude H.

Science. 2012 Jan 27;335(6067):472-5. doi: 10.1126/science.1215659.

36.

Anogenital pseudotumoral herpes and HIV infection: a new challenge for diagnosis and treatment.

Di Lucca-Christment J, Jacobelli S, Gressier L, Plantier F, Laude H, Rozenberg F, Morini JP, Dallot A, Avril MF, Dupin N.

AIDS. 2012 Feb 20;26(4):523-6. doi: 10.1097/QAD.0b013e32835049be. Erratum in: AIDS. 2013 Sep 24;27(15):2499. Rosenberg, Flore [corrected to Rozenberg, Flore].

PMID:
22210631
37.

Atypical scrapie isolates involve a uniform prion species with a complex molecular signature.

Götte DR, Benestad SL, Laude H, Zurbriggen A, Oevermann A, Seuberlich T.

PLoS One. 2011;6(11):e27510. doi: 10.1371/journal.pone.0027510. Epub 2011 Nov 11.

38.

Expression of the prion-like protein Shadoo in the developing mouse embryo.

Young R, Bouet S, Polyte J, Le Guillou S, Passet B, Vilotte M, Castille J, Beringue V, Le Provost F, Laude H, Vilotte JL.

Biochem Biophys Res Commun. 2011 Dec 9;416(1-2):184-7. doi: 10.1016/j.bbrc.2011.11.021. Epub 2011 Nov 10.

PMID:
22093825
39.

Characterization of spontaneously generated prion-like conformers in cultured cells.

Zou RS, Fujioka H, Guo JP, Xiao X, Shimoji M, Kong C, Chen C, Tasnadi M, Voma C, Yuan J, Moudjou M, Laude H, Petersen RB, Zou WQ.

Aging (Albany NY). 2011 Oct;3(10):968-84.

40.

Variation in Chst8 gene expression level affects PrPC to PrPSc conversion efficiency in prion-infected Mov cells.

Martin R, Chantepie S, Chapuis J, Le-Duc A, Maftah A, Papy-Garcia D, Laude H, Petit JM, Gallet PF.

Biochem Biophys Res Commun. 2011 Oct 28;414(3):587-91. doi: 10.1016/j.bbrc.2011.09.126. Epub 2011 Oct 1.

PMID:
21982770
41.

Use of murine bioassay to resolve ovine transmissible spongiform encephalopathy cases showing a bovine spongiform encephalopathy molecular profile.

Beck KE, Sallis RE, Lockey R, Vickery CM, Béringue V, Laude H, Holder TM, Thorne L, Terry LA, Tout AC, Jayasena D, Griffiths PC, Cawthraw S, Ellis R, Balkema-Buschmann A, Groschup MH, Simmons MM, Spiropoulos J.

Brain Pathol. 2012 May;22(3):265-79. doi: 10.1111/j.1750-3639.2011.00526.x. Epub 2011 Oct 13.

42.

The sialic acid binding activity of the S protein facilitates infection by porcine transmissible gastroenteritis coronavirus.

Schwegmann-Wessels C, Bauer S, Winter C, Enjuanes L, Laude H, Herrler G.

Virol J. 2011 Sep 12;8:435. doi: 10.1186/1743-422X-8-435.

43.

Generation of Sprn-regulated reporter mice reveals gonadic spatial expression of the prion-like protein Shadoo in mice.

Young R, Le Guillou S, Tilly G, Passet B, Vilotte M, Castille J, Beringue V, Le Provost F, Laude H, Vilotte JL.

Biochem Biophys Res Commun. 2011 Sep 9;412(4):752-6. doi: 10.1016/j.bbrc.2011.08.049. Epub 2011 Aug 17.

PMID:
21871438
44.

Transcriptomic analysis brings new insight into the biological role of the prion protein during mouse embryogenesis.

Khalifé M, Young R, Passet B, Halliez S, Vilotte M, Jaffrezic F, Marthey S, Béringue V, Vaiman D, Le Provost F, Laude H, Vilotte JL.

PLoS One. 2011;6(8):e23253. doi: 10.1371/journal.pone.0023253. Epub 2011 Aug 15.

45.

Sheep and goat BSE propagate more efficiently than cattle BSE in human PrP transgenic mice.

Padilla D, Béringue V, Espinosa JC, Andreoletti O, Jaumain E, Reine F, Herzog L, Gutierrez-Adan A, Pintado B, Laude H, Torres JM.

PLoS Pathog. 2011 Mar;7(3):e1001319. doi: 10.1371/journal.ppat.1001319. Epub 2011 Mar 17.

46.

High levels of antibodies against merkel cell polyomavirus identify a subset of patients with merkel cell carcinoma with better clinical outcome.

Touzé A, Le Bidre E, Laude H, Fleury MJ, Cazal R, Arnold F, Carlotti A, Maubec E, Aubin F, Avril MF, Rozenberg F, Tognon M, Maruani A, Guyetant S, Lorette G, Coursaget P.

J Clin Oncol. 2011 Apr 20;29(12):1612-9. doi: 10.1200/JCO.2010.31.1704. Epub 2011 Mar 21.

PMID:
21422439
47.

Atypical/Nor98 scrapie infectivity in sheep peripheral tissues.

Andréoletti O, Orge L, Benestad SL, Beringue V, Litaise C, Simon S, Le Dur A, Laude H, Simmons H, Lugan S, Corbière F, Costes P, Morel N, Schelcher F, Lacroux C.

PLoS Pathog. 2011 Feb 10;7(2):e1001285. doi: 10.1371/journal.ppat.1001285.

48.

Prion propagation in cells expressing PrP glycosylation mutants.

Salamat MK, Dron M, Chapuis J, Langevin C, Laude H.

J Virol. 2011 Apr;85(7):3077-85. doi: 10.1128/JVI.02257-10. Epub 2011 Jan 19.

49.

Epidermodysplasia verruciformis in human immunodeficiency virus-infected patients: a marker of human papillomavirus-related disorders not affected by antiretroviral therapy.

Jacobelli S, Laude H, Carlotti A, Rozenberg F, Deleuze J, Morini JP, Franck N, Gorin I, Avril MF, Dupin N.

Arch Dermatol. 2011 May;147(5):590-6. doi: 10.1001/archdermatol.2010.399. Epub 2011 Jan 17.

PMID:
21242344
50.

Lipschütz genital ulceration associated with mumps.

Chanal J, Carlotti A, Laude H, Wallet-Faber N, Avril MF, Dupin N.

Dermatology. 2010;221(4):292-5. doi: 10.1159/000319857. Epub 2010 Oct 1. Review.

PMID:
20924156

Supplemental Content

Support Center